[go: up one dir, main page]

SI1902054T1 - Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba - Google Patents

Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba

Info

Publication number
SI1902054T1
SI1902054T1 SI200630273T SI200630273T SI1902054T1 SI 1902054 T1 SI1902054 T1 SI 1902054T1 SI 200630273 T SI200630273 T SI 200630273T SI 200630273 T SI200630273 T SI 200630273T SI 1902054 T1 SI1902054 T1 SI 1902054T1
Authority
SI
Slovenia
Prior art keywords
åpyrimidine
pyrido
derivatives
preparation
same
Prior art date
Application number
SI200630273T
Other languages
English (en)
Inventor
Pierre Casellas
Bernard Bourrie
Pierre Perreaut
Claude Muneaux
Samir Jegham
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SI1902054T1 publication Critical patent/SI1902054T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200630273T 2005-07-01 2006-06-29 Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba SI1902054T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507032A FR2887882B1 (fr) 2005-07-01 2005-07-01 Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
EP06778710A EP1902054B1 (fr) 2005-07-01 2006-06-29 Derives de pyrido[2,3-d]pyrimidine, leur preparation, leur application en therapeutique

Publications (1)

Publication Number Publication Date
SI1902054T1 true SI1902054T1 (sl) 2009-06-30

Family

ID=36096420

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200631750T SI2020410T1 (sl) 2005-07-01 2006-06-29 Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba
SI200630273T SI1902054T1 (sl) 2005-07-01 2006-06-29 Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200631750T SI2020410T1 (sl) 2005-07-01 2006-06-29 Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba

Country Status (41)

Country Link
US (2) US7504406B2 (sl)
EP (2) EP1902054B1 (sl)
JP (1) JP4472009B2 (sl)
KR (1) KR101298344B1 (sl)
CN (2) CN102260258B (sl)
AR (1) AR054812A1 (sl)
AT (1) ATE423119T1 (sl)
AU (1) AU2006264801B2 (sl)
BR (1) BRPI0613020A2 (sl)
CA (1) CA2610794C (sl)
CR (1) CR9568A (sl)
CY (2) CY1110457T1 (sl)
DE (1) DE602006005246D1 (sl)
DK (2) DK1902054T3 (sl)
DO (1) DOP2006000145A (sl)
EA (1) EA014312B1 (sl)
EC (1) ECSP078011A (sl)
ES (2) ES2322101T3 (sl)
FR (1) FR2887882B1 (sl)
HK (1) HK1122797A1 (sl)
HR (2) HRP20090236T1 (sl)
IL (1) IL187900A0 (sl)
JO (1) JO2550B1 (sl)
MA (1) MA29561B1 (sl)
ME (1) ME01813B (sl)
MX (1) MX2007016239A (sl)
MY (1) MY143089A (sl)
NO (1) NO20080418L (sl)
NZ (1) NZ564072A (sl)
PA (1) PA8684801A1 (sl)
PE (1) PE20070139A1 (sl)
PL (2) PL1902054T3 (sl)
PT (2) PT1902054E (sl)
RS (2) RS53211B (sl)
SI (2) SI2020410T1 (sl)
TN (1) TNSN07440A1 (sl)
TW (1) TWI321566B (sl)
UA (1) UA92021C2 (sl)
UY (1) UY29645A1 (sl)
WO (1) WO2007003765A1 (sl)
ZA (1) ZA200711032B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
CA2739901A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators
EP2344484B1 (en) * 2008-10-17 2016-06-08 Akaal Pharma Pty Ltd S1p receptors modulators and use thereof
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CN103204827B (zh) * 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
EP2638911A1 (en) 2012-03-14 2013-09-18 Sanofi Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
WO1996015128A2 (en) 1994-11-14 1996-05-23 Warner-Lambert Company 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
YU50402A (sh) * 2000-01-25 2005-11-28 Warner-Lambert Company Pirido(2,3-d)pirimidin-2,7-diaminski inhibitori kinaze
CZ20022929A3 (cs) * 2000-03-06 2003-02-12 Warner-Lambert Company 5-Alkylpyrido[2,3-d]pyrimidinové inhibitory tyrosinových kinas
ES2311532T3 (es) 2000-08-04 2009-02-16 Warner-Lambert Company Llc 2-(4-pirdil)amino-6-dialcoxifenil-pirido(2.3-d)pirimidin-7-onas.
WO2003000011A2 (en) * 2001-06-21 2003-01-03 Ariad Pharmaceuticals, Inc. Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
US20050009849A1 (en) 2003-01-03 2005-01-13 Veach Darren R. Pyridopyrimidine kinase inhibitors
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

Also Published As

Publication number Publication date
EA200800223A1 (ru) 2008-06-30
DOP2006000145A (es) 2008-01-31
MA29561B1 (fr) 2008-06-02
EA014312B1 (ru) 2010-10-29
US7504406B2 (en) 2009-03-17
DK2020410T3 (en) 2014-03-24
TWI321566B (en) 2010-03-11
PL2020410T3 (pl) 2014-05-30
BRPI0613020A2 (pt) 2010-12-14
DE602006005246D1 (de) 2009-04-02
US8008310B2 (en) 2011-08-30
PT2020410E (pt) 2014-03-20
ZA200711032B (en) 2009-04-29
CN102260258A (zh) 2011-11-30
RS53211B (en) 2014-08-29
US20090163522A1 (en) 2009-06-25
PT1902054E (pt) 2009-04-22
ME01813B (me) 2014-09-20
JP2008544975A (ja) 2008-12-11
SI2020410T1 (sl) 2014-04-30
PA8684801A1 (es) 2007-01-17
CN101213196B (zh) 2011-09-07
CA2610794A1 (fr) 2007-01-11
US20080176874A1 (en) 2008-07-24
CY1114989T1 (el) 2016-12-14
TNSN07440A1 (en) 2009-03-17
EP1902054B1 (fr) 2009-02-18
FR2887882B1 (fr) 2007-09-07
EP2020410B1 (fr) 2013-12-18
ATE423119T1 (de) 2009-03-15
IL187900A0 (en) 2008-03-20
AR054812A1 (es) 2007-07-18
ES2450067T3 (es) 2014-03-21
KR20080021714A (ko) 2008-03-07
PL1902054T3 (pl) 2009-07-31
JP4472009B2 (ja) 2010-06-02
HRP20140246T1 (hr) 2014-06-20
CA2610794C (fr) 2012-02-21
WO2007003765A1 (fr) 2007-01-11
UY29645A1 (es) 2007-01-31
EP2020410A1 (fr) 2009-02-04
ECSP078011A (es) 2008-01-23
NZ564072A (en) 2012-02-24
AU2006264801B2 (en) 2012-05-10
CN102260258B (zh) 2015-01-07
CN101213196A (zh) 2008-07-02
HK1122797A1 (en) 2009-05-29
NO20080418L (no) 2008-03-28
MX2007016239A (es) 2008-03-06
MY143089A (en) 2011-03-15
KR101298344B1 (ko) 2013-08-20
HRP20090236T1 (en) 2009-05-31
CY1110457T1 (el) 2015-04-29
EP1902054A1 (fr) 2008-03-26
AU2006264801A1 (en) 2007-01-11
RS50781B (sr) 2010-08-31
JO2550B1 (en) 2010-09-05
UA92021C2 (ru) 2010-09-27
TW200745102A (en) 2007-12-16
PE20070139A1 (es) 2007-03-07
FR2887882A1 (fr) 2007-01-05
ES2322101T3 (es) 2009-06-16
DK1902054T3 (da) 2009-06-15
CR9568A (es) 2008-02-20

Similar Documents

Publication Publication Date Title
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL186881A (en) Pyrido derivatives [3,2– d] pyrimidine and their uses for the manufacture of drugs against hcv
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
EP1863811A4 (en) IMIDAZO [1,2-A] PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
HK1103730A1 (en) Pyrrolopyridine derivatives and their use as crth2antagonists
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
SI1902054T1 (sl) Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba
IL182624A0 (en) 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
SI2448939T1 (sl) Derivati 2,3-dihidro-1H-imidazo(1,2-a)pirimidin-5-ona, njihova priprava in farmacevtska uporaba
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL182385A0 (en) Pyridine derivatives and the preparation and the therapeutic use thereof
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
ZA201004520B (en) N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds,preparation thereof and therapeutic application thereof
IL206669A0 (en) 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
ZA201004641B (en) Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL206672A0 (en) N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
IL206667A0 (en) 2-HETEROAROYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
HK1107340A1 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof